AviadoBio
AviadoBio is developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).
- Sector
Healthcare
- Country
United Kingdom
- Fund
LSP Dementia Fund
- Entry
2021
Website

Founded in 2003 and headquartered in Lehi, Utah, Avetta’s innovative SaaS platform enables customers to mitigate supply chain risk complexity by managing supplier risk factors across health, safety and sustainability, among other risk vectors. The two-sided network of clients and suppliers facilitates contractor prequalification and worker competency management at scale across major industries globally, resulting in reduced accident levels, improved compliance rates, higher levels of operational, sustainability, and ethical excellence, and increased supplier eligibility for jobs.
Market trends and drivers
Global supply chains face increasing complexity from globalization and digitization, as well as heightened safety, compliance and sustainability requirements. Backed by decades of innovation and established global scale across industries, Avetta helps companies mitigate this complexity and drive sustainable resilience for clients and suppliers.
Investment potential
EQT will support Avetta in its growth and innovation journey through the development of new products and technologies that enhance the value proposition for both hiring clients and suppliers, adoption of AI / automation, and global expansion to make global supply chains more resilient, safe, and sustainable.
Board of directors
Chairperson
Scott Stephenson
Board member
Shanti Atkins
Board member
Arvindh Kumar
Board member
Tyler Parker
Management
CEO
Arshad Matin
CFO
Brandon Grinwis
Do You Want to Know More?
We are eager to explore how we can achieve great things together.